View Author
patient cancer study treatment colorectal colorectal cancer incidence dopamine polyposi hyperprolactinemia outpatient treatment mutyh-associated control patients surgery diagnosis control survival agonist outpatient dopamine agonists hospital disease prevalence netherland mutyh-associated polyposis embolism department incidence rate prolactinoma endocrinol center tumor thrombosis syndrome university cohort stage venou metab cushing result event dopamine agonist-treated hyperprolactinemia venous thromboembolism postoperative vte person-year criteria table incidence rates dopamine agonist women population colon period analysis follow-up 3 months month erasmus university rotterdam level therapy pharmacy outcome agonist-treated subject leiden prescription postoperative acth-dependent cs mortality cortisol prede fined criteria database thromboembolism prolactin number transsphenoidal surgery study period record idiopathic hyperprolactinemia
4 Most Recent Publications
|
Incidence of venous thromboembolism in patients with Cushing's syndrome: A multicenter cohort study
(Article)
Stuijver, D.J.F. Zaane, B. van Kerstens, M.N. Zelissen, P.M. Fliers, E. Schaper, N. Drent, M.L. Dekkers, O.M. Gerdes, V.E.A. Feelders, R.A. Debeij, J. Cannegieter, S.C. Hermus, A.R.M.M. Berg, G. van den Pereira, A.M. Herder, W.W. de Wagenmakers, M.A.E.M. |
2011-11-01
|
|
Outpatient treatment in patients with acute pulmonary embolism: The Hestia Study
(Article)
Zondag, W. Mos, I.C.M. Jonkers, G.J.P.M. Kralingen, K.W. van Kruip, M.J.H.A. Vlasveld, T. Vreede, M.J.M. de Huisman, M.V. Creemers-Schild, D. Hoogerbrugge, A.D.M. Dekkers, O.M. Dolsma, J. Eijsvogel, M. Faber, L.M. Hofstee, H.M.A. Hovens, M.M.C. |
2011-08-01
|
|
Survival of MUTYH-associated polyposis patients with colorectal cancer and matched control colorectal cancer patients
(Article)
Nielsen, M. Steenbergen, L.N. van Hes, F.J. Jones, N. Vogt, S. Vasen, H.F. Morreau, H. Aretz, S. Sampson, J. Dekkers, O.M. Janssen-Heijnen, M.L.G. |
2010-11-01
|
|
Estimated age- and sex-specific incidence and prevalence of dopamine agonist-treated hyperprolactinemia
(Article)
Kars, M. Souverein, P. Herings, R.M.C. Romijn, J.A. Vandenbroucke, J.P. Boer, A. de Dekkers, O.M. |
2009-08-01
|